216 related articles for article (PubMed ID: 24662263)
1. Niacin activates the G protein estrogen receptor (GPER)-mediated signalling.
Santolla MF; De Francesco EM; Lappano R; Rosano C; Abonante S; Maggiolini M
Cell Signal; 2014 Jul; 26(7):1466-75. PubMed ID: 24662263
[TBL] [Abstract][Full Text] [Related]
2. AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs).
Cirillo F; Lappano R; Bruno L; Rizzuti B; Grande F; Guzzi R; Briguori S; Miglietta AM; Nakajima M; Di Martino MT; Maggiolini M
J Exp Clin Cancer Res; 2019 Aug; 38(1):335. PubMed ID: 31370872
[TBL] [Abstract][Full Text] [Related]
3. GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells.
Vivacqua A; Romeo E; De Marco P; De Francesco EM; Abonante S; Maggiolini M
Breast Cancer Res Treat; 2012 Jun; 133(3):1025-35. PubMed ID: 22147081
[TBL] [Abstract][Full Text] [Related]
4. MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells.
Lappano R; Santolla MF; Pupo M; Sinicropi MS; Caruso A; Rosano C; Maggiolini M
Breast Cancer Res; 2012 Jan; 14(1):R12. PubMed ID: 22251451
[TBL] [Abstract][Full Text] [Related]
5. GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells.
Rigiracciolo DC; Scarpelli A; Lappano R; Pisano A; Santolla MF; Avino S; De Marco P; Bussolati B; Maggiolini M; De Francesco EM
Oncotarget; 2016 Jan; 7(1):94-111. PubMed ID: 26646587
[TBL] [Abstract][Full Text] [Related]
6. Two novel GPER agonists induce gene expression changes and growth effects in cancer cells.
Lappano R; Rosano C; Santolla MF; Pupo M; De Francesco EM; De Marco P; Ponassi M; Spallarossa A; Ranise A; Maggiolini M
Curr Cancer Drug Targets; 2012 Jun; 12(5):531-42. PubMed ID: 22414008
[TBL] [Abstract][Full Text] [Related]
7. GPER, IGF-IR, and EGFR transduction signaling are involved in stimulatory effects of zinc in breast cancer cells and cancer-associated fibroblasts.
Pisano A; Santolla MF; De Francesco EM; De Marco P; Rigiracciolo DC; Perri MG; Vivacqua A; Abonante S; Cappello AR; Dolce V; Belfiore A; Maggiolini M; Lappano R
Mol Carcinog; 2017 Feb; 56(2):580-593. PubMed ID: 27341075
[TBL] [Abstract][Full Text] [Related]
8. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
[TBL] [Abstract][Full Text] [Related]
9. Estrogenic gper signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (cafs).
Vivacqua A; De Marco P; Santolla MF; Cirillo F; Pellegrino M; Panno ML; Abonante S; Maggiolini M
Oncotarget; 2015 Jun; 6(18):16573-87. PubMed ID: 26030000
[TBL] [Abstract][Full Text] [Related]
10. Distinct kinetic and spatial patterns of protein kinase C (PKC)- and epidermal growth factor receptor (EGFR)-dependent activation of extracellular signal-regulated kinases 1 and 2 by human nicotinic acid receptor GPR109A.
Li G; Deng X; Wu C; Zhou Q; Chen L; Shi Y; Huang H; Zhou N
J Biol Chem; 2011 Sep; 286(36):31199-212. PubMed ID: 21768093
[TBL] [Abstract][Full Text] [Related]
11. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
Santolla MF; Avino S; Pellegrino M; De Francesco EM; De Marco P; Lappano R; Vivacqua A; Cirillo F; Rigiracciolo DC; Scarpelli A; Abonante S; Maggiolini M
Cell Death Dis; 2015 Jul; 6(7):e1834. PubMed ID: 26225773
[TBL] [Abstract][Full Text] [Related]
12. The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells.
Lappano R; Mallet C; Rizzuti B; Grande F; Galli GR; Byrne C; Broutin I; Boudieu L; Eschalier A; Jacquot Y; Maggiolini M
Cells; 2019 Jun; 8(6):. PubMed ID: 31207943
[TBL] [Abstract][Full Text] [Related]
13. GPER activates Notch signaling in breast cancer cells and cancer-associated fibroblasts (CAFs).
Pupo M; Pisano A; Abonante S; Maggiolini M; Musti AM
Int J Biochem Cell Biol; 2014 Jan; 46():56-67. PubMed ID: 24275097
[TBL] [Abstract][Full Text] [Related]
14. Dynamic monitoring of GPER-mediated estrogenic effects in breast cancer associated fibroblasts: An alternative role of estrogen in mammary carcinoma development.
Luo H; Liu M; Luo S; Yu T; Wu C; Yang G; Tu G
Steroids; 2016 Aug; 112():1-11. PubMed ID: 27016131
[TBL] [Abstract][Full Text] [Related]
15. The G protein estrogen receptor (GPER) is regulated by endothelin-1 mediated signaling in cancer cells.
Bartella V; De Francesco EM; Perri MG; Curcio R; Dolce V; Maggiolini M; Vivacqua A
Cell Signal; 2016 Feb; 28(2):61-71. PubMed ID: 26607335
[TBL] [Abstract][Full Text] [Related]
16. GPER mediates activation of HIF1α/VEGF signaling by estrogens.
De Francesco EM; Pellegrino M; Santolla MF; Lappano R; Ricchio E; Abonante S; Maggiolini M
Cancer Res; 2014 Aug; 74(15):4053-64. PubMed ID: 24894716
[TBL] [Abstract][Full Text] [Related]
17. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
18. The nuclear localization signal is required for nuclear GPER translocation and function in breast Cancer-Associated Fibroblasts (CAFs).
Pupo M; Vivacqua A; Perrotta I; Pisano A; Aquila S; Abonante S; Gasperi-Campani A; Pezzi V; Maggiolini M
Mol Cell Endocrinol; 2013 Aug; 376(1-2):23-32. PubMed ID: 23748028
[TBL] [Abstract][Full Text] [Related]
19. A genetic polymorphism repurposes the G-protein coupled and membrane-associated estrogen receptor GPER to a transcription factor-like molecule promoting paracrine signaling between stroma and breast carcinoma cells.
Pupo M; Bodmer A; Berto M; Maggiolini M; Dietrich PY; Picard D
Oncotarget; 2017 Jul; 8(29):46728-46744. PubMed ID: 28596490
[TBL] [Abstract][Full Text] [Related]
20. GPER in CAFs regulates hypoxia-driven breast cancer invasion in a CTGF-dependent manner.
Ren J; Guo H; Wu H; Tian T; Dong D; Zhang Y; Sui Y; Zhang Y; Zhao D; Wang S; Li Z; Zhang X; Liu R; Qian J; Wei H; Jiang W; Liu Y; Li Y
Oncol Rep; 2015 Apr; 33(4):1929-37. PubMed ID: 25647524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
